Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Københavns Universitets forskningsportal Forside
Hjælp og OSS
Dansk
English
Forside
Profiler
Publikation
Forskningsenheder
Presse/medier
Aktiviteter
Priser
???studenttheses???
Forskningsdatasæt
Søg efter ekspertise, navn eller tilknytning
Treat-and-Extend versus Monthly Regimen in Neovascular Age-Related Macular Degeneration: Results with Ranibizumab from the TREND Study
TREND Study Group
Institut for Klinisk Medicin
89
Citationer (Scopus)
10
Downloads (Pure)
Oversigt
Fingeraftryk
Fingeraftryk
Dyk ned i forskningsemnerne om 'Treat-and-Extend versus Monthly Regimen in Neovascular Age-Related Macular Degeneration: Results with Ranibizumab from the TREND Study'. Sammen danner de et unikt fingeraftryk.
Sorter
Vægt
Alfabetisk
Keyphrases
Ranibizumab
100%
Neovascular Age-related Macular Degeneration (nAMD)
100%
Treatment Group
33%
Visual Acuity
22%
Central Subfield Thickness
22%
Baseline Characteristics
11%
Adverse Events
11%
Age 50
11%
Patient-completed
11%
Best-corrected Visual Acuity
11%
Interventional Study
11%
Well-balancing
11%
Treatment Safety
11%
Non-inferiority
11%
Change from Baseline
11%
Least Mean Square
11%
Safety Signal
11%
Treatment Exposure
11%
Nave
11%
Letter to the
11%
Pharmacology, Toxicology and Pharmaceutical Science
Ranibizumab
100%
Wet Macular Degeneration
100%
Treatment Group
50%
Adverse Event
16%